Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TAILOR-PANC: Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)

NCT07802418 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT07802418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07802418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TAILOR-PANC: Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer (DPCG-02)
Lead sponsor
Herlev Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
June 30, 2032
Enrollment
1,200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer